Evaluating a New Device for Personalized Thyroid Disorder Treatment
NCT03517579 · RecruitingThis trial is studying a new device called the Collar Therapy Indicator (CoTI) to help improve radioiodine treatment for thyroid disorders, including thyroid cancer and Graves' disease. The CoTI measures radiation exposure continuously, which may give doctors better information than traditional methods. The goal is to personalize treatment to help patients achieve better results while reducing unnecessary visits to the clinic.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- Johns Hopkins HospitalBaltimore, MarylandRecruiting
Who can join
This study is open to adults aged 21 to 65, both men and women. You can join if you have Graves' disease confirmed by lab tests or differentiated thyroid cancer needing treatment. You must be able to understand simple English and follow instructions. However, people with certain neck problems or who are pregnant cannot join. The trial team will confirm your eligibility.
What happens during the trial
Participants will be part of a pilot study group of 10 people. They will wear the CoTI device, which is a collar that continuously measures radiation exposure. Everyone in the study will receive their usual treatment based on established methods. The trial will not use the CoTI measurements to change treatments during this study.
The trial team
The trial is run by Johns Hopkins University. The principal investigator is Dr. Prasanna Santhanam, who leads the research team.
Important dates
The trial started on December 11, 2018, and is currently recruiting new participants. It is expected to finish by December 15, 2027.
Additional information
The trial's ID number is NCT03517579. This is a pilot study and is not FDA-regulated. The trial hopes to include 10 participants.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →